(MS1098)
H2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR) (ab131383)
Overview
- Product nameH2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR)
- Precision
Intra-assay Sample n Mean SD CV% HeLa Cells < 10% - Tests1 x 96 well plate
- Sample typeAdherent cells, Suspension cells
- Assay typeCell-based
- Species reactivityReacts with: Human
- Product overview
The H2A.X (pS139) and cleaved-PARP Human In-Cell ELISA Kit (IR) (ab131383) is designed to study the induction of DNA damage and/or apoptosis in response to various stimuli. Monoclonal antibodies specific to phospho-H2A.X (S139) and cleaved-PARP are used in the high-throughput duplexing plate-based assay. H2A.X is a histone H2A family member that is phosphorylated and recruited to sites of double-strand DNA breaks. Poly [ADP-ribose] polymerase 1 (PARP) is a DNA repair enzyme that is cleaved by activated caspases. Combined, these antibodies provide biomarkers of dsDNA breaks (pH2A.X) and apoptosis (cleaved-PARP).
- Tested applicationsIn-Cell ELISA more details
Properties
- Storage instructionsStore at +4°C. Please refer to protocols.
-
Components 1 x 96 tests 1000X IRDye-labeled Secondary Antibodies 1 x 24µl 100X Anti-cleaved-PARP Primary Antibody (Mouse Monoclonal) 1 x 120µl 100X Anti-H2A.X (pSer139) Rabbit Primary Antibody 1 x 120µl 100X Triton X-100 1 x 0.5ml 10X Blocking Buffer 1 x 10ml 10X Phosphate Buffered Saline 1 x 100ml 400X Tween-20 1 x 2ml Janus Green Stain 1 x 17ml -
Research Areas
- SwissProt: P16104 Human
- SwissProt: P09874 Human
- SwissProt: P11103 Human
- SwissProt: P11103 Human
Applications
Our Abpromise guarantee covers the use of ab131383 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| In-Cell ELISA | In-Cell ELISA |
H2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR) images
-
Sample experiment using ab131383 on HeLa cells following drug treatment: H2A.X (pSer139) readout. HeLa cells were treated for 4 hours with dose titrations of Camptothecin, Etoposide and Staurosporin. The data (presented as mean +/- SD) were analyzed as described in Data Analysis section. The dashed grey line indicates the vehicle control signal.
-
Sample experiment using ab131383 on HeLa cells following drug treatment: cleaved-PARP readout. HeLa cells were treated for 4 hours with dose titrations of Camptothecin, Etoposide and Staurosporin. The data (presented as mean +/- SD) were analyzed as described in Data Analysis section. The dashed grey line indicates the vehicle control signal.
-
Immunocytochemistry/ Immunofluorescence - H2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR) (ab131383)Specificity of H2A.X (pSer139) and cleaved-PARP antibodies demonstrated by immunocytochemistry. Primary antibodies used in this assay kit were validated by staining HeLa cells treated with 10 µM Camptothecin or vehicle for 4 hours and imaged by fluorescent microscopy. Note the absence of H2A.X (pSer139) and cleaved-PARP signal in the untreated cells. -
All lanes : H2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR) (ab131383)
Lane 1 : Untreated cells
Lane 2 : Camptothecin treated cells
Lane 3 : UV exposed cells -
Antibody specificity demonstrated by Western Blot Analysis: H2A.X (pSer139) is phospho-specific. Jurkat cells were stimulated with UV light exposure to induce H2A.X (pSer139) and then the UV treated lysate was treated with lambda protein phosphatase. Top panel: H2A.X (pSer139) is induced by UV treatment and the western blot band is sensitive to phosphatase treatment. Lower panel: In contrast, total H2A.X (ab124781) levels are not sensitive to phosphatase treatment.
Protocols
References for H2A.X (pSer139) + Cleaved-PARP Human In-Cell ELISA Kit (IR) (ab131383)
ab131383 has not yet been referenced specifically in any publications.



